The impact of PEAR 1 polymorphism on clinical outcomes in Chinese patients receiving dual antiplatelet therapy after percutaneous coronary intervention

被引：6
|
作者：
Hu, Xinyuan [1 ]
Liu, Chaoxi [2 ]
Zhang, Mingyou [2 ]
Zhang, Weihua [2 ]
机构：
[1] First Hosp Jilin Univ, Genet Diag Ctr, Changchun 130021, Peoples R China
[2] First Hosp Jilin Univ, Dept Cardiol, Changchun 130021, Peoples R China
来源：
PHARMACOGENOMICS | 2022年 / 23卷 / 11期
关键词：
aspirin; genetic polymorphisms; PCI; PEAR1; CLOPIDOGREL RESPONSIVENESS; PLATELET REACTIVITY; RECEPTOR;
D O I：
10.2217/pgs-2022-0033
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Background: Patients might still experience major adverse cardiovascular events even with dual antiplatelet therapy after percutaneous coronary intervention. Our study aimed to explore the impact of gene polymorphism on clinical outcomes in one-year follow-up. Methods: A total of 171 patients treated with dual antiplatelet therapy after percutaneous coronary intervention from April to December 2020 in the first hospital of Jilin University enrolled in this study. Results: PEAR1 genetic polymorphisms was associated with the arachidonic acid (AA) and adenosine diphosphate (ADP) platelet aggregation. Hyperglycemia was associated with the rate of major adverse cardiovascular events. PEAR1 GA+AA genetic genetic polymorphisms is associated with hyperglycemia. Conclusion: PEAR1 GG is a risk factor for AA and ADP platelet aggregation. Hyperglycemia can effect the one-year outcome. PEAR1 GA+AA genetic polymorphisms are associated with hyperglycemia.
引用
收藏
页码：639 / 648
页数：10
相关论文
共 50 条
  • [31] Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention
    Yao, Yi
    Tang, Xiao-fang
    Zhang, Jia-hui
    He, Chen
    Ma, Yuan-liang
    Xu, Jing-jing
    Song, Ying
    Liu, Ru
    Meng, Xian-min
    Song, Lei
    Chen, Jue
    Wang, Miao
    Xu, Bo
    Gao, Run-lin
    Yuan, Jin-qing
    THROMBOSIS RESEARCH, 2016, 141 : 28 - 34
  • [32] Variation in Aspirin Dose in Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    Matteau, Alexis
    Yeh, Robert W.
    Orav, F. J.
    Kereiakes, Dean I.
    Massaro, Joseph
    Wimmer, Neil J.
    Vasaiwala, Samip
    Mauri, Maura
    CIRCULATION, 2012, 126 (21)
  • [33] Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy
    DeEugenio, Deborah
    Kolman, Louis
    DeCaro, Matthew
    Andrel, Jocelyn
    Chervoneva, Inna
    Duong, Phu
    Lam, Linh
    McGowan, Christopher
    Lee, Grace
    DeCaro, Mark
    Ruggiero, Nicholas
    Singhal, Shalabh
    Greenspon, Arnold
    PHARMACOTHERAPY, 2007, 27 (05): : 691 - 696
  • [34] Optimizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Older Adults
    Khan, Safi U.
    Kleiman, Neal S.
    JAMA NETWORK OPEN, 2024, 7 (03)
  • [35] Dual antiplatelet therapy after percutaneous coronary intervention: entering the final chapter?
    Capodanno, Davide
    EUROINTERVENTION, 2019, 15 (06) : E475 - E478
  • [36] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, O.
    Perez, X.
    Pierre-Louis, B.
    Kurian, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 512 - 512
  • [37] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, Olusegun
    Perez, Xavier
    Bredy-Pierre-Louis
    Kurian, Damian
    CARDIOLOGY JOURNAL, 2016, 23 (03) : 307 - 316
  • [38] Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
    Han, Jialun
    Zhang, Yi
    Shi, Xiujin
    Lin, Baidi
    Zhang, Yunnan
    Zhang, Ru
    Wang, Yifan
    Yan, Jialin
    Lin, Yang
    GLOBAL HEART, 2023, 18 (01)
  • [39] 1 Month of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention The New Standard?
    Giri, Jay
    Fanaroff, Alexander C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (21) : 2073 - 2075
  • [40] Endoscopy findings in patients on dual antiplatelet therapy following percutaneous coronary intervention
    Galusko, Victor
    Protty, Majd
    Haboubi, Hasan N.
    Verhemel, Sarah
    Bundhoo, Shantu
    Yeoman, Andrew D.
    POSTGRADUATE MEDICAL JOURNAL, 2022, 98 (1162) : 591 - 597
12345